Press release: Icosagen Develops Manufacturing-Ready CHO Cell Line for EPOK Therapeutics’ Complex Tetravalent Antibody-Like Protein 15.09 ->
Icosagen CRDMO Receives Its Fourth French Research Tax Credit (CIR) Accreditation, Valid Through 2030 06.08 ->
